Status:
UNKNOWN
Early Fall Risk Detection and Fall Prevention Among Inpatients With Delirium
Lead Sponsor:
University Department of Geriatric Medicine FELIX PLATTER
Collaborating Sponsors:
University of Basel
Velux Stiftung
Conditions:
Delirium in Old Age
Delirium Superimposed on Dementia
Eligibility:
All Genders
65+ years
Brief Summary
During delirium patients are at risk of severe harm due to unattended bed-exits resulting in falls. This research intends to explore how effective alarming contact mats (CareMat®) in comparison to con...
Detailed Description
Delirium is a neuropsychiatric disorder with a sudden and reversible decline in attention and cognition due to a medical condition.8 Delirium is associated with emotional distress for patients, their ...
Eligibility Criteria
Inclusion
- Admission at or transferal to DelirUnit. During Covid pandemic, patients will be enrolled into the study after the second negative Covid swab (PCR).
Exclusion
- Patients who have been sectioned and must be treated in a facility, whether they agree or not (under the mental health act) (Fürsorgliche Unterbringung).
- No proxy consent available due to language barriers;
- Missing legal proxy in case of lacking family network
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05391334
Start Date
November 1 2022
End Date
June 30 2024
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitäre Altersmedizin Felix Platter
Basel, Switzerland, 4055